Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Sanofi (SNY) Return on Invested Capital (2016 - 2026)

Sanofi's Return on Invested Capital history spans 16 years, with the latest figure at 0.0% for Q1 2026.

  • On a quarterly basis, Return on Invested Capital changed 0.0% to 0.0% in Q1 2026 year-over-year; TTM through Mar 2026 was 0.0%, a 0.0% change, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Return on Invested Capital hit 0.0% in Q1 2026 for Sanofi, up from 0.0% in the prior quarter.
  • Over the last five years, Return on Invested Capital for SNY hit a ceiling of 0.04% in Q2 2023 and a floor of 0.0% in Q4 2024.
  • Historically, Return on Invested Capital has averaged 0.01% across 5 years, with a median of 0.0% in 2023.
  • Biggest five-year swings in Return on Invested Capital: rose 1bps in 2023 and later decreased -2bps in 2024.
  • Tracing SNY's Return on Invested Capital over 5 years: stood at 0.0% in 2022, then decreased by -13bps to 0.0% in 2023, then tumbled by -51bps to 0.0% in 2024, then increased by 4bps to 0.0% in 2025, then rose by 1bps to 0.0% in 2026.
  • Business Quant data shows Return on Invested Capital for SNY at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.01% in Q3 2025.